Peer Review Report For: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda [version 1; peer review: 1 approved, 1 approved with reservations]

Read full text Summarise with VIRAT

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Hemoglobinopathies and Related Disorders Malaria Research and Control Blood groups and transfusion

Publication details

Journal / source
Wellcome Open Research
Publication date
1 April 2026
Language
EN